| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
|
|
| Synonyms | MDL-100,907 |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.123.797 |
| Chemical and physical data | |
| Formula | C22H28FNO3 |
| Molar mass | 373.46 g/mol |
| 3D model (Jmol) | |
|
|
Volinanserin (INN) (developmental code name MDL-100,907) is a highly selective 5-HT2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT2A receptor. It was also tested in clinical trials as a potential antipsychotic,antidepressant, and treatment for insomnia but was never marketed.